PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses

Chu-Han Feng; Linda Peltier; Tiffanie Chouleur; Milea DiPonzio; Isabelle Aubry; Alexandre J Poirier; Zuzet M Cordova; Yunyun Shen; Sébastien Tabariès; Xiaona Cao; Guojun Chen; Andreas Bikfalvi; Silvia M Vidal; Peter M Siegel; Pierre Laneuville; Michel L Tremblay

doi:https://doi.org/10.1038/s44319-026-00745-0

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses

Identifier:nobleid.org/w1/20260418/393739CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/393739CF.svg?ark=w1%2F20260418%2F393739CF)](https://nobleid.org/work/w1/20260418/393739CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

PTPN1/PTPN2 inhibition improves NK cancer therapy by enhancing IL-2 and mitigating TGFβ1 responses

Identifier:nobleid.org/w1/20260418/393739CF

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/393739CF.svg?ark=w1%2F20260418%2F393739CF)](https://nobleid.org/work/w1/20260418/393739CF)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work